Home/Filings/4/0001567619-19-018607
4//SEC Filing

Furnas Matthew 4

Accession 0001567619-19-018607

CIK 0001311241other

Filed

Sep 19, 8:00 PM ET

Accepted

Sep 20, 4:36 PM ET

Size

9.0 KB

Accession

0001567619-19-018607

Insider Transaction Report

Form 4
Period: 2019-09-20
Furnas Matthew
DirectorOther
Transactions
  • Disposition from Tender

    Stock Option

    2019-09-2025,0000 total
    Exercise: $1.39Common Stock (25,000 underlying)
  • Disposition from Tender

    Stock Option

    2019-09-2075,0000 total
    Exercise: $0.96Common Stock (75,000 underlying)
Footnotes (3)
  • [F1]On September 20, 2019, pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 6, 2019, by and among EMD Group Holding II, Inc. ("Parent"), EMD Performance Materials Semiconductor Services Corp. ("Merger Sub") and Intermolecular, Inc. (the "Company"), Merger Sub merged with and into the Company, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Company Shares," and each such share, a "Company Share") (other than Canceled Company Shares and Dissenting Company Shares) was thereupon canceled and converted into the right to receive $1.20 in cash (the "Merger Consideration"), with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger").
  • [F2]The options are fully vested due to vesting acceleration approved by the board in connection with the Merger.
  • [F3]Pursuant to the Merger Agreement, (i) each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the effective time of the merger (the "Effective Time") was accelerated, (ii) each Company Option that remained outstanding as of immediately prior to the Effective Time was canceled and terminated as of the Effective Time and (iii) the Reporting Person of such Company Option became entitled to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of company Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the per share exercise price of such Company Option.

Documents

1 file

Issuer

INTERMOLECULAR INC

CIK 0001311241

Entity typeother

Related Parties

1
  • filerCIK 0001702477

Filing Metadata

Form type
4
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 4:36 PM ET
Size
9.0 KB